Sort   by:  
 Page size 
Genomicsrenal cell carcinoma
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
ORGANISM(S): Homo sapiens 
2015-06-19 | E-GEOD-66885 | biostudies-arrayexpress
GenomicsGenome-wide maps of H3K36me3 in metastatic renal cell carcinoma and isogenic renal cell carcinoma cell lines
We report the application of H3K36me3 ChIP sequencing in SETD2 genotyped samples Examination of H3K36me3 in SETD2 wild-type, mutant renal cell carcinoma and SETD2 isogenic cell lines
ORGANISM(S): Homo sapiens 
2015-06-19 | E-GEOD-66884 | biostudies-arrayexpress
UnknownSafety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors.
Not available
S-EPMC5657013 | biostudies-literature
UnknownBevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
Not available
S-EPMC5006186 | biostudies-literature
UnknownA phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma.
Not available
S-EPMC4754667 | biostudies-literature
UnknownQuality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial.
Not available
S-EPMC6804841 | biostudies-literature
UnknownAdjuvant and neoadjuvant therapy in renal cell carcinoma.
Not available
S-EPMC3895463 | biostudies-literature
UnknownPlasma cytokine and angiogenic factors associated with prognosis and therapeutic response to sunitinib vs everolimus in advanced non-clear cell renal cell carcinoma.
Not available
S-EPMC5522056 | biostudies-literature
UnknownRandomized controlled trial of expressive writing for patients with renal cell carcinoma.
Not available
S-EPMC3927735 | biostudies-literature
UnknownAssociation of Body Mass Index With the Safety Profile of Nivolumab With or Without Ipilimumab.
Not available
S-EPMC9857666 | biostudies-literature
Sort   by:  
 Page size